Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹101Cr
Rev Gr TTM
Revenue Growth TTM
-35.80%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ATHENAGLO
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -58.1 | -29.5 | 39.0 | 18.9 | 88.5 | 23.7 | 72.7 | 5.8 | -26.3 | -27.6 | -41.2 | -47.3 |
| 8 | 7 | 4 | 6 | 17 | 6 | 5 | 4 | 7 | 4 | 6 | 9 |
Operating Profit Operating ProfitCr |
| -283.2 | -104.2 | -60.5 | -55.0 | -331.9 | -51.8 | -19.2 | -0.7 | -145.3 | -46.4 | -138.1 | -304.1 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 236 | 0 | 0 | 0 | 0 | 0 | 0 | 24 |
Interest Expense Interest ExpenseCr | 2 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 3 | 3 | 3 | 7 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -8 | -6 | -4 | -6 | 222 | -5 | -4 | -4 | -7 | -4 | -6 | 9 |
| 0 | 0 | 1 | -2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 8 |
|
Growth YoY PAT Growth YoY% | -165.0 | -106.3 | 35.1 | -15.3 | 3,041.3 | 23.2 | 8.4 | 8.8 | -103.1 | 8.4 | -35.8 | 129.7 |
| -360.6 | -183.1 | -202.4 | -106.3 | 5,627.6 | -113.7 | -107.3 | -91.7 | -238.1 | -143.7 | -247.9 | 51.6 |
| -5.6 | -4.6 | -3.8 | -2.7 | 164.9 | -3.4 | -3.3 | -2.7 | -4.9 | -3.1 | -4.4 | 0.8 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 18.0 | | -24.5 | 77.2 | 86.7 | -1.3 | -22.8 | -40.3 | 14.7 | 13.4 | -31.6 |
| 12 | 7 | 14 | 11 | 14 | 26 | 28 | 28 | 27 | 34 | 23 | 27 |
Operating Profit Operating ProfitCr |
| -84.5 | 9.7 | -31.2 | -33.0 | -1.4 | 0.9 | -6.5 | -37.9 | -128.1 | -147.6 | -46.3 | -148.5 |
Other Income Other IncomeCr | 0 | 0 | 1 | 4 | 2 | 2 | 2 | 9 | 1 | 237 | 1 | 24 |
Interest Expense Interest ExpenseCr | 0 | 0 | 1 | 1 | 2 | 3 | 3 | 9 | 7 | 10 | 12 | 16 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 4 | 3 | 0 | 1 | 0 | 1 | 1 |
| -6 | 1 | -3 | 0 | -1 | -4 | -5 | -8 | -23 | 206 | -19 | -9 |
| 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | -1 | 1 | 1 | 8 |
|
| | 110.0 | | 109.7 | -479.2 | -353.0 | -12.6 | -24.9 | -173.0 | 1,030.7 | -109.8 | 18.3 |
| -87.8 | 7.5 | -32.4 | 4.2 | -8.9 | -21.7 | -24.8 | -40.1 | -183.3 | 1,488.0 | -128.9 | -153.9 |
| -7.0 | 0.7 | -3.1 | 0.3 | -1.1 | -3.8 | -5.7 | -6.2 | -16.5 | 153.3 | -14.3 | -11.6 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 8 | 8 | 10 | 11 | 11 | 11 | 12 | 13 | 13 | 14 | 14 | 15 |
| -17 | -17 | -21 | -20 | -21 | -23 | -7 | -5 | -24 | 185 | 165 | 130 |
Current Liabilities Current LiabilitiesCr | 9 | 9 | 13 | 11 | 12 | 19 | 27 | 25 | 23 | 58 | 95 | 114 |
Non Current Liabilities Non Current LiabilitiesCr | 16 | 16 | 12 | 19 | 26 | 27 | 25 | 44 | 82 | 68 | 67 | 61 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 8 | 9 | 6 | 10 | 12 | 15 | 15 | 17 | 24 | 16 | 19 | 23 |
Non Current Assets Non Current AssetsCr | 7 | 7 | 8 | 13 | 17 | 18 | 44 | 60 | 71 | 309 | 322 | 296 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 3 | 0 | 0 | 5 | -1 | 9 | 5 | -4 | -21 | 12 | 10 |
Investing Cash Flow Investing Cash FlowCr | -4 | 0 | -2 | -3 | -3 | -10 | -7 | -9 | -13 | -5 | -4 |
Financing Cash Flow Financing Cash FlowCr | 1 | 0 | 1 | -1 | 4 | 2 | 1 | 12 | 35 | -8 | -5 |
|
Free Cash Flow Free Cash FlowCr | 2 | 0 | -2 | 5 | -2 | 5 | 5 | -7 | -21 | 12 | 10 |
| -46.7 | 1.8 | -2.8 | 1,428.0 | 94.3 | -155.8 | -84.3 | 51.3 | 94.2 | 5.8 | -47.7 |
CFO To EBITDA CFO To EBITDA% | -48.5 | 1.4 | -2.9 | -181.3 | 605.4 | 3,825.0 | -323.7 | 54.3 | 134.8 | -58.0 | -132.9 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 8 | 6 | 26 | 16 | 51 | 41 | 42 | 92 | 67 | 126 | 128 |
Price To Earnings Price To Earnings | 0.0 | 11.1 | 0.0 | 42.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 |
Price To Sales Price To Sales | 1.2 | 0.8 | 2.5 | 2.0 | 3.6 | 1.6 | 1.6 | 4.6 | 5.6 | 9.2 | 8.2 |
Price To Book Price To Book | -0.8 | -0.7 | -2.4 | -1.7 | -5.5 | -3.6 | 7.9 | 11.3 | -6.5 | 0.6 | 0.7 |
| -2.0 | 11.9 | -9.0 | -7.0 | -269.5 | 195.7 | -30.0 | -17.9 | -9.1 | -10.4 | -31.3 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 87.7 | 75.4 | 57.3 | 75.5 | 92.6 |
| -84.5 | 9.7 | -31.2 | -33.0 | -1.4 | 0.9 | -6.5 | -37.9 | -128.1 | -147.6 | -46.3 |
| -87.8 | 7.5 | -32.4 | 4.2 | -8.9 | -21.7 | -24.8 | -40.1 | -183.3 | 1,488.0 | -128.9 |
| 86.2 | -9.3 | 38.1 | -23.2 | -21.4 | 14.9 | -13.3 | 2.0 | -24.7 | 75.8 | -2.6 |
| 58.6 | -6.2 | 31.9 | -3.5 | 13.7 | 50.5 | -121.7 | -100.0 | 214.4 | 103.2 | -11.3 |
| -37.5 | 3.6 | -24.2 | 1.5 | -4.3 | -17.0 | -11.1 | -10.4 | -23.2 | 63.1 | -5.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Athena Global Technologies Limited (AGTL) is a Hyderabad-based diversified enterprise with a strategic footprint in the **USA** and **UK**. The company operates a multi-driver growth model, leveraging its core competencies in software development and digital transformation to scale high-growth subsidiaries in the **EdTech**, **HealthTech**, and **Commercial Real Estate** sectors.
---
### **Core Technical Competencies & Digital Pillars**
AGTL positions itself as a provider of "smart, autonomous decision-making" systems. The company underwent a brand refresh in **August 2024** to reflect this shift toward AI-driven, digital-first service delivery.
| Service Category | Key Offerings & Technologies |
| :--- | :--- |
| **AI & Cognitive** | Real-time customer interactions, **virtual predictive/diagnostic applications**, and cognitive automation. |
| **Automation & Robotics** | **Robotic Process Automation (RPA)**, Chatbots, and Voicebots across all device ecosystems. |
| **Data Science** | Actionable intelligence models and data analytics for operational efficiency. |
| **Emerging Tech** | **Blockchain** ("Internet of Value") and **IoT-based solutions** for customer engagement. |
| **Software Engineering** | Product Engineering, **QA & Testing** (acting as production environment custodians), and Cloud-native development. |
---
### **Diversified Business Segments & Subsidiary Ecosystem**
The Group’s operations are categorized into six primary reporting segments, executed through specialized subsidiaries:
* **Software Services:** Core IT activities including development, maintenance, consulting, and QA. This segment reported a **21.7%** year-on-year growth as of late 2024.
* **MedleyMed (HealthTech):** Operates an **Online Pharmacy Platform** and **Online Trade of Pharma**. It provides B2B and B2C medicine delivery, telemedicine, and pharmacy logistics. AGTL recently acquired **100%** of **Medleymed Healthcare Solutions Private Limited** and established **MedleyMed, Inc.** in the **USA**.
* **Tutoroot (EdTech):** A wholly owned subsidiary providing **Online Education Services**. It focuses on personalized learning for K-12, university programs, and **competitive examinations** in India and abroad.
* **Real Estate & Leasing:** Revenue derived from the sale and lease of residential and commercial units. The cornerstone of this segment is the **Phoenix Centaurus Project** in Hyderabad’s Financial District.
---
### **Strategic Asset: The Phoenix Centaurus Project**
AGTL holds a significant stake in a major commercial real estate asset that serves as a primary vehicle for debt servicing and liquidity:
* **Ownership:** AGTL holds a **~5 lakh sq. ft.** share in this **~21 lakh sq. ft.** project (a 5-acre joint development with Phoenix Tech Zone).
* **Key Tenant:** In July 2025, the company leased **125,048.98 sq. ft.** (the entire 16th floor) to **FedEx Express**.
* **Valuation:** Following the completion of the Manikonda project, the company recognized buildings under investment property at a fair value of **₹239 crore**, resulting in a one-time "Other Income" increase of **₹235.94 crore** in FY25.
* **Monetization:** The company has approved the sale or lease of up to **1,50,000 Sq. Ft.** of this SEZ property to fund operations and debt obligations.
---
### **Financial Performance & Capital Structure**
The company demonstrated a massive turnaround in **FY 2023-24**, though liquidity remains a point of scrutiny.
**Consolidated Financial Highlights:**
| Metric (₹ in Crore) | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- |
| **Total Income** | **250.35** | **12.60** |
| **Net Profit / (Loss)** | **205.10** | **(22.03)** |
| **Revenue from Operations** | **9.71** | **9.80** |
| **Foreign Exchange Earnings** | **8.18** | **6.87** |
**Capital Raising & Restructuring:**
To manage working capital and debt, the company has utilized several instruments:
* **Convertible Warrants:** Issued **7,00,000** warrants at **₹84** (Apr 2026), **6,50,000** warrants at **₹87** (Feb 2024), and **6,70,000** warrants at **₹59** (May 2023) to the Promoter Group.
* **Borrowing Limits:** Increased to **₹350 Crores** to support expansion.
* **Equity Status:** **94.03%** of equity shares are dematerialized (**ISIN: INE576B01019**).
---
### **Debt Profile & Liquidity Status**
As of December 2024, liquidity was characterized as **Poor** due to a negative EBITDA of **₹13.18 crore** against interest obligations of **₹11.00 crore** for FY24.
* **Non-Current Borrowings:** Reduced to **₹57.88 Crore** (March 2024) from **₹66.26 Crore** (March 2023).
* **Secured Loans:** **₹52.86 Crore** hypothecated against the 15th and 16th floors of the Centaurus complex, held with **Axis Finance** and **Aditya Birla Finance**.
* **NCD Withdrawal:** In **March 2025**, AGTL voluntarily withdrew a proposed **₹150 crore** NCD issue after failing to meet sanction letter conditions, leading to the withdrawal of its **IVR C/Stable** rating.
* **Related Party Loans:** As of Sep 2025, AGTL has extended **₹14.44 Crore** to Medley Medical and **₹6.85 Crore** to Tutoroot.
---
### **Risk Matrix & Mitigation Strategies**
| Risk Category | Primary Exposure & Impact |
| :--- | :--- |
| **Debt Servicing** | Ongoing **delays and irregularities** in servicing obligations; risk of lenders calling loans if covenants are breached. |
| **Market Concentration** | Over **90%** of projected medium-term revenue is derived from **export markets** (Healthcare/Finance). |
| **Competitive Pressure** | High pricing pressure from larger, well-capitalized IT service providers. |
| **Real Estate Cyclicality** | Volatility in leasing revenues and dependence on asset monetization for liquidity. |
| **Human Capital** | High demand for digital skills makes talent acquisition and retention a critical challenge. |
| **Financial Risks** | Exposure to **Foreign Exchange** fluctuations and **Salary Inflation** impacting defined benefit obligations. |
### **Future Outlook**
AGTL is prioritizing **innovation-led differentiation** and **operational efficiency** to return to sustainable profitability. The strategy hinges on:
1. **Asset Monetization:** Utilizing the **Centaurus SEZ** to deleverage the balance sheet.
2. **Niche Verticals:** Tailoring AI and Blockchain solutions for **Fintech, Logistics, and Healthcare**.
3. **Global Expansion:** Scaling the **MedleyMed** platform in the US market and expanding **Tutoroot’s** digital training reach.